RAFA OTC
Rafarma Pharmaceuticals, Inc.
1W: -13.5%
1M: +6.7%
3M: +60.0%
YTD: +17.0%
1Y: -33.3%
3Y: -86.1%
5Y: -97.4%
$0.03
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$12M
-0.8% ▼
5Y CAGR: -10.1%
Total Liabilities
$2M
-0.2% ▼
5Y CAGR: -32.1%
Shareholders Equity
$10M
-0.9% ▼
5Y CAGR: +2.6%
Cash & Investments
$77K
-6.1% ▼
5Y CAGR: -44.2%
Total Debt
$0
+0.0% ▲
Net Debt
-$77K
+6.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5M | $14M | $18M | $66K | $77K |
| Short-Term Investments | $677K | $27K | $781K | $0 | $0 |
| Cash & ST Investments | $6M | $14M | $19M | $66K | $77K |
| Net Receivables | $24M | $20M | $15M | $2M | $2M |
| Inventory | $14M | $21M | $20M | $93K | $156K |
| Other Current Assets | $217K | $0 | -$1K | $0 | $0 |
| Total Current Assets | $44M | $55M | $54M | $2M | $2M |
| Property, Plant & Equip. | $22M | $28M | $40M | $115K | $114K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2M | $2M | $712K | $0 | $50K |
| Other Non-Current Assets | $2M | $3M | $3M | $10M | $10M |
| Total Non-Current Assets | $27M | $34M | $44M | $10M | $10M |
| Total Assets | $71M | $89M | $98M | $12M | $12M |
| — Liabilities — | |||||
| Accounts Payable | $17M | $17M | $17M | $2M | $2M |
| Short-Term Debt | $30K | $2M | $360K | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $218K | $246K | $86K | $79K |
| Total Current Liabilities | $18M | $19M | $18M | $2M | $2M |
| Long-Term Debt | $466K | $89K | $549K | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $1M | $785K | $3M | $0 | $0 |
| Total Liabilities | $19M | $20M | $20M | $2M | $2M |
| — Equity — | |||||
| Common Stock | $9M | $87K | $87K | $37K | $87K |
| Retained Earnings | $30M | $60M | $55M | $408K | $280K |
| Accumulated OCI | $12M | $10M | $23M | $10M | $10M |
| Total Stockholders Equity | $52M | $70M | $78M | $11M | $10M |
| Total Liabilities & Equity | $71M | $89M | $98M | $12M | $12M |
| — Key Metrics — | |||||
| Total Debt | $496K | $2M | $909K | $0 | $0 |
| Net Debt | -$5M | -$12M | -$17M | -$66K | -$77K |
| Total Investments | $3M | $2M | $1M | $0 | $50K |